C4A.112
Merkel cell carcinoma of right lower eyelid, including canthus
Clinical Classification Guidelines
Medical Intelligence & Overview
Merkel cell carcinoma is a rare and aggressive skin cancer that originates in the Merkel cells—touch receptor cells located in the skin. When this type of carcinoma affects the right lower eyelid, including the canthus (corner of the eye), it presents unique challenges due to the delicate anatomy of the eyelid area. Early detection and treatment are crucial to manage the disease effectively and preserve eye function and appearance.
Causes & Symptoms
Clinical Causes: UV radiation exposure from sunlight or tanning beds Weakened immune system due to conditions like HIV or immunosuppressive therapies Extended exposure to environmental toxins or chemicals Previous skin injuries or scars in the eyelid region Older age, as the risk increases with age Having a weakened immune response due to certain medical conditions
Key Symptoms: Slowly enlarging firm, painless nodules on the eyelid Lumps that may be reddish, bluish, or skin-colored Brightness or shininess of the lesion Ulceration or bleeding from the growth Swelling of nearby lymph nodes Changes in skin texture or color around the eyelid
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves a combination of clinical examination and biopsy. The healthcare provider will examine the eyelid carefully, checking for abnormal skin changes or lumps. A tissue sample is collected and examined under a microscope to confirm the presence of Merkel cell carcinoma. Additional tests such as imaging scans (MRI, CT, or PET scans) may be utilized to determine whether the cancer has spread to surrounding tissues or distant organs, guiding treatment planning.
Treatment Protocols: Treatment strategies for Merkel cell carcinoma of the eyelid aim to remove the tumor completely and prevent recurrence. Options include: - Surgical excision: Removing the tumor with a margin of healthy tissue, often followed by reconstructive procedures to restore eyelid function. - Radiation therapy: To destroy residual cancer cells or in cases where surgery is not feasible. - Immunotherapy: Emerging treatments that boost the body's immune response against cancer cells. - Chemotherapy: Less common, used if the cancer has spread extensively. Follow-up care involves regular monitoring to detect any signs of recurrence or metastasis, with the possibility of additional treatments if necessary.
Clinical Advice & FAQs
Billing Guidance
Is C4A.112 a billable ICD-10 code?
Yes, C4A.112 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C4A.112?
Clinical documentation must specify the nature of Merkel cell carcinoma of right lower eyelid, including canthus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
